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a  b  s  t  r  a  c  t
A better understanding of the antimicrobial susceptibility, carriage of virulence determi-
nants and molecular characteristics of Staphylococcus aureus isolates associated with skin
and  soft tissue infections (SSTIs) may provide further insights related to clinical outcomes
with these infections. From January 2012 to September 2013, a total of 128 non-duplicate
S.  aureus isolates were recovered from patients with SSTIs. All 128 S. aureus SSTI isolates
carried at least ﬁve virulence genes tested. Virulence genes detected among at least 70%
of  all tested isolates included hld (100%), hla (95.3%), icaA (96.9%), clf (99.2%), sdrC (79.7%),
sdrD (70.3%), and sdrE (72.7%). The prevalence of MRSA isolates with 10 virulence genes
tested (54.4%, 31/56) was signiﬁcantly higher than that among MSSA isolates (35.2%, 25/71)
(p  < 0.05). The positive rates of seb,  sen, sem, sdrE and pvl among MRSA isolates were sig-
niﬁcantly higher than among MSSA isolates (p < 0.05). ST7 and ST630 accounting for 10.9%
were found to be the predominant STs. The most prevalent spa type was t091 (8.6%). MRSA-
ST59-SCCmec IV was the most common clone (12.3%) among MRSA isolates whereas among
MSSA isolates the dominant clone was MSSA-ST7 (15.5%). Six main clonal complexes (CCs)
were  found, including CC5 (52.3%), CC7 (11.7%), CC59 (8.6%), CC88 (6.3%), CC398 (4.7%), and
CC121  (3.1%). A higher carriage of seb and sec was found among CC59 isolates. In compari-
son to CC5 and CC7 isolates, those with the highest carriage rates (>80.0%) of sdrC and sdrD,CC59 isolates had lower prevalence of these two virulence genes. All CC59 isolates were
icin and trimethoprim/sulfamethoxazole, while CC5 and CC7 isolatessusceptible to gentamhad  resistance rates to these two antimicrobials of 25.4% and 20.9%, and 40.0% and 40.0%,
respectively. The resistance rates for tetracycline, clindamycin, and erythromycin among
CC5 isolates were lower than among CC7 and CC59 isolates. In conclusion, the molecular
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typing of S. aureus SSTI isolates in the present study showed considerable heterogeneity.
ST7  and ST630 became prevailing clones. Different S. aureus clones causing SSTIs were
associated with speciﬁc antimicrobial resistance and virulence gene proﬁles.
© 2015 Elsevier Editora Ltda. All rights reserved.
I
S
a
s
t
s
s
T
f
o
a
r
m
t
t
l
g
f
u
S
f
h
t
o
S
t
M
t
(
s
i
C
a
a
m
S
f
p
b
f
t
w
U
i
s
s
c
i
introduction
taphylococcus aureus,  particularly methicillin-resistant S.
ureus (MRSA), is an important human pathogen respon-
ible for many  infectious diseases including skin and soft
issue infections (SSTIs), foreign-body infections, pneumonia,
eptic arthritis, endocarditis, osteomyelitis, sepsis, and blood-
tream infections in both hospital and community settings.1
he ability of this clinically important pathogen to success-
ully persist within the hosts is largely due to the carriage
f a battery of virulence factors which promote adhesion,
cquisition of nutrients, and evasion of host immunologic
esponses.2,3 Some S. aureus isolates also produce one or
ore  additional exoproteins, such as toxic shock syndrome
oxin-1 (TSST-1), staphylococcal enterotoxins (SEs), exfoliative
oxins (ETs), and leukocidins.2–4 Recently, Panton-Valentine
eukocidin (pvl) encoded by two contiguous and cotranscribed
enes (lukS-PV and lukF-PV) is an important virulence factor
or community-acquired MRSA (CA-MRSA) affecting individ-
als without apparent risk factors for hospital acquisition.5,6
. aureus is the most common bacterial pathogen identiﬁed
rom SSTIs.7 SSTIs caused by MRSA is associated with a
igh incidence of treatment failure and recurrence.8 A bet-
er understanding of the antimicrobial susceptibility, carriage
f virulence determinants, and molecular characteristics of
. aureus isolates associated with SSTIs may provide fur-
her insights related to clinical outcomes of these infections.
olecular typing has proved to be an important tool to inves-
igate MRSA epidemiology. Pulsed-ﬁeld gel electrophoresis
PFGE) patterns, SCCmec typing, spa typing, and multi-locus
equence typing (MLST) have been proven useful for monitor-
ng the evolutionary process of pandemic MRSA clones.1 In
hina, ST239-MRSA-III is a predominant MRSA clone among
dults, while ST59-MRSA-IV is the most prevalent clone
mong children.9,10 In a previous study we investigated the
olecular typing of S. aureus isolated from patients with
STIs at our hospital from December 2002 to June 2008 and
ound that ST239, ST1018, ST59, ST7, and ST88 were the most
revalent sequence types.11 A shift of important clones has
een observed in several studies.12–14 A report from China
ound a rapid change of MRSA over a 15-year period at a
ertiary care hospital, when the ST239-MRSA-III-t037 clone
as replaced by the emerging ST239-MRSA-III-t030 clone.15
nderstanding the shift of important clones at the local and
nternational levels is of great signiﬁcance. To understand the
hift of S. aureus clones associated with SSTIs, the present
tudy aimed to investigate the antimicrobial susceptibility,
arriage of virulence determinants, and molecular character-
stics of S. aureus isolates associated with SSTIs at the hospital
n 2012–2013.Materials  and  methods
Collection  of  clinical  isolates  and  S.  aureus  conﬁrmation
From January 2012 to September 2013, a total of 128 non-
duplicate S. aureus isolates (single isolate per patient) were
collected at The First Afﬁliated Hospital of Wenzhou Medical
University, China from pus samples of hospitalized patients
with SSTIs. Lesions requiring incision and drainage or with
spontaneously draining purulent ﬂuid, carbuncles, furuncles,
boils, cellulitis with purulent drainage, chronic ulcer, and deep
wounds were included. S. aureus isolates from patients with
SSTIs with clinical signs and symptoms of infection such
as increased white blood cell counts, fever, local redness,
swelling, and exudate were considered invasive isolates and
included for investigation. Isolates were identiﬁed as S. aureus
using Gram stain, positive catalase and coagulase test results,
and Vitek microbiology analyzer (bioMérieu, Marcy  l’Etoile,
France). S. aureus ATCC25923 was used as a control strain.
Ethics  statement
This study was approved by the Institutional Ethics Review
Board of The First Afﬁliated Hospital of Wenzhou Medical Uni-
versity. All patients provided written informed consent for
this study. The written informed consents were also obtained
from the next of kin, caretakers, or guardians on behalf of the
minors/children enrolled.
Antimicrobial  susceptibility  testing
S. aureus susceptibility to penicillin (10 units), eryth-
romycin (15 g), clindamycin (2 g), rifampicin (5 g),
tetracycline(30 g), linezolid (30 g), mupirocin (5 g), quin-
upristin/dalfopristin (15 g), trimethoprim/sulfamethoxazole
(1.25/23.75 g), gentamicin (10 g), ciproﬂoxacin (5 g),
Chloramphenicol (30 g), and nitrofurantoin (300 g) were
determined using disc diffusion test recommended by the
Clinical and Laboratory Standards Institute (CLSI).16 All
discs were obtained from Oxoid Ltd. Vancomycin MICs for
S. aureus isolates were determined by agar dilution method.
Interpretive standards for the antimicrobial susceptibility test
and D-test for tested S. aureus isolates were in accordance
with the guidelines provided by CLSI.16 Susceptibility of S.
aureus to mupirocin was determined by disc diffusion, with
a zone diameter ≥14 mm on a 5 g disc indicating suscepti-
bility as described previously.17,18 S. aureus ATCC 25923 and
Escherichia coli ATCC25922 were used as reference strains for
antimicrobial susceptibility testing.
i s . 2 0616  b r a z j i n f e c t d 
DNA  extraction
S. aureus isolates tested were cultured on blood agar overnight
at 35 ◦C. Then, three to four bacterial colonies were sus-
pended and incubated in 150 L sterile distilled water with
lysostaphin (1 mg/mL) (Sangon, China) at 37 ◦C for 1 h. Finally,
DNA was extracted following the instructions of the Genomic
DNA Extraction kit (Sangon, China). The extracted DNA was
stored at −20 ◦C and prepared for PCR detection.
Identiﬁcation  of  MRSA  isolates  and  pvl  detection
A multiplex PCR protocol was used for simultaneous ampli-
ﬁcation of mecA, 16S rRNA, and pvl genes as described
previously.19 MRSA isolates harbouring mecA were conﬁrmed
using MRSA N315 and pvl-positive MRSA isolate identiﬁed in
our previous study as positive control strains.20
Detection  of  virulence  genes
Virulence genes, including toxins (sea, seb, sec,  sed,  seg,  seh, sei,
sej, seo,  sen, sem, edin, hla,  hlb, hld, hlg,  tst,  eta,  etb), adhesins
(clfA, cna,  sdrC, sdrD, and sdrE), icaA and arcA were identi-
ﬁed using PCR assays with primers and conditions previously
described.21,22 PCR primers used for PCR assays were shown
in Table 1.
S. aureus isolates harbouring virulence genes determined
in our previous study were used as positive control strains for
detecting virulence genes.20
SCCmec  typing
SCCmec  typing of MRSA isolates was performed using a
battery of multiplex PCRs as described previously.23 MRSA
isolates with unanticipated fragments or lacking fragments
by multiplex PCR were deﬁned as non-typeable (NT). MRSA
NCTC 10442 (SCCmecI), MRSA N315 (SCCmec II), MRSA 85/2082
(SCCmec  III), MRSA JCSC 4744 (SCCmec IV), and MRSA WZ153
(SCCmec  V) were used as control strains for SCCmec typing.
spa  typing
The spa variable repeat region from each S. aureus isolate
was ampliﬁed using simplex PCR oligonucleotide primers
as previously described.24,25 Following their puriﬁcation and
sequencing, spa types were assigned using the spa database
website (http://www.ridom.de/spaserver).
Multi-locus  sequence  typing  (MLST)
MLST typing of S. aureus isolates was performed using ampliﬁ-
cation of internal fragments of the seven housekeeping genes
26of S. aureus as described previously. Following puriﬁcation
and sequencing of these genes, the sequences were compared
with the existing sequences available on the MLST website for
S. aureus (http://saureus.mlst.net), and STs were determined
according to the allelic proﬁles. Novel STs were deposited in
the MLST database (http://saureus.mlst.net/). 1 5;1  9(6):614–622
Statistical  analysis
Differences between groups were assessed by using the chi-
square test. The software SPSS 13.0 was used to perform
calculations. p-Values of <0.05 were considered statistically
signiﬁcant.
Results  and  discussion
Antimicrobial  susceptibility
Among 128 S. aureus isolates, 57 (44.5%) were identiﬁed as
MRSA determined by cefoxitin disc diffusion test and were
positive for mecA. The MRSA prevalence in the present study
was  lower than the 54.1% reported between December 2002
and June 2008.11 The resistance rates for S. aureus,  MRSA,
and MSSA isolates to antimicrobials are listed in Table 2.
All isolates tested were susceptible to vancomycin, linezolid,
dalfopristin/quinupristin, and nitrofurantoin. Of 128 S. aureus
isolates, 72.7% (93/128) with resistance to three or more  classes
of antimicrobial agents tested were deﬁned as multidrug-
resistant isolates. Only two  isolates tested were susceptible to
all antimicrobial agents tested. Twenty-three (18.0%) isolates
were only resistant to penicillin. Ten (7.8%) isolates were con-
comitantly resistant to two antimicrobial agents tested (peni-
cillin and another antimicrobial agent). Resistance rates of S.
aureus, MRSA, and MSSA isolates to penicillin, clindamycin,
and gentamicin were above 60%, whereas to tetracycline,
gentamicin, ciproﬂoxacin, trimethoprim/sulfamethoxazole,
chloramphenicol and rifampicin were less than 40%. Three
isolates were positive for D-test, indicating that resistance of
these isolates to clindamycin was inducible. Only one MRSA
isolate was resistant to mupirocin as it exhibited no zone of
inhibition.
Virulence  gene  proﬁling
The invasiveness of S. aureus largely depends on the carriage
of a battery of virulence factors.2,3 All S. aureus SSTI isolates
in the present study harboured at least ﬁve virulence genes
tested. Frequencies of virulence genes are shown in Table 3.
Virulence genes were detected among at least 70% of all tested
isolates included hld (100%), hla (95.3%), icaA (96.9%), clf (99.2%),
sdrC (79.7%), sdrD (70.3%), and sdrE (72.7%). Less than 10% of
the isolates tested carried eta (7.0%), sed (6.3%), seh (7.0%), tst
(4.7%), and edin (5.5%). Multiple isolates harboured pvl (12.5%),
sea (35.9%), seb (14.8%), sec (21.1%), sei (21.1%), seg (26.6%), sem
(30.5%), sen (31.3%), seo (27.3%), hlb (22.7%), hlg (18.8%), and cna
(32.0%). All S. aureus isolates tested were negative for sej,  etb,
and arcA. Fifty-six (43.75%, 56/128) isolates harboured more
than 10 tested virulence genes, among which two isolates har-
boured 16 genes, seven isolates 14 genes, 13 isolates 13 genes,
six isolates 12 genes, 10 isolates 11 genes, and 18 isolates 10
genes. Of MRSA isolates, 54.4% (31/56) harboured more than
10 tested virulence genes, which was signiﬁcantly higher than
that among MSSA isolates (35.2%, 25/71) (p < 0.05).
Staphylococcal enterotoxins (SEs), including ﬁve major
classical antigenic types of SEs (SEA to SEE) and newly  iden-
tiﬁed SEs are the cause of food poisoning in humans.27
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Table 1 – PCR primers used for PCR assays.
PCR product Primer description Primer sequence Refs.
sea sea-Up
sea-Dn
TTGCAGGGAACAGCTTTAGGCAATC
TGGTGTACCACCCGCACATTGA
21
seb seb-Up
seb-Dn
GACATGATGCCTGCACCAGGAGA
AACAAATCGTTAAAAACGGCGACACAG
21
sec sec-Up
sec-Dn
CCCTACGCCAGATGAGTTGCACA
CGCCTGGTGCAGGCATCATATC
21
sed sed-Up
sed-Dn
GAAAGTGAGCAAGTTGGATAGATTGCGGCTAG
CCGCGCTGTATTTTTCCTCCGAGAG
21
see see-Up
see-Dn
TGCCCTAACGTTGACAACAAGTCCA
TCCGTGTAAATAATGCCTTGCCTGAA
21
seg seg-Up
seg-Dn
TGCTCAACCCGATCCTAAATTAGACGA
CCTCTTCCTTCAACAGGTGGAGACG
21
seh seh-Up
seh-Dn
CATTCACATCATATGCGAAAGCAGAAG
GCACCAATCACCCTTTCCTGTGC
21
sei sei-Up
sei-Dn
TGGAGGGGCCACTTTATCAGGA
TCCATATTCTTTGCCTTTACCAGTG
21
sej
sem
sen
seo
sej-Up
sej-Dn
sem-Up
sem-Dn
sen-Up
sen-Dn
seo-Up
seo-Dn
CTCCCTGACGTTAACACTACTAATAACCC
TATGGTGGAGTAACACTGCATCAAAA
CTATTAATCTTTGGGTTAATGGAGAAC
TTCAGTTTCGACAGTTTTGTTGTCAT
ATGAGATTGTTCTACATAGCTGCAAT
AACTCTGCTCCCACTGAAC
AGTTTGTGTAAGAAGTCAAGTGTAGA
ATCTTTAAATTCAGCAGATATTCCATCTAAC
21
22
22
22
tst tst-Up
tst-Dn
AGCCCTGCTTTTACAAAAGGGGAAAA
CCAATAACCACCCGTTTTATCGCTTG
21
eta eta-Up
eta-Dn
CGCTGCGGACATTCCTACATGG
TACATGCCCGCCACTTGCTTGT
21
etb
hla
hlb
hld
hlg
etb-Up
etb-Dn
hla-Up
hla-Dn
hlb-Up
hlb-Dn
hld-Up
hld-Dn
hlg-Up
hlg-Dn
GAAGCAGCCAAAAACCCATCGAA
TGTTGTCCGCCTTTACCACTGTGAA
CTGATTACTATCCAAGAAATTCGATTG
CTTTCCAGCCTACTTTTTTATCAGT
GTGCACTTACTGACAATAGTGC
GTTGATGAGTAGCTACCTTCAGT
AAGAATTTTTATCTTAATTAAGGAAGGAGTG
TTAGTGAATTTGTTCACTGTGTCGA
GTCAYAGAGTCCATAATGCATTTAA
CACCAAATGTATAGCCTAAAGTG
21
22
22
22
22
sdrC sdrC-Up
sdrC-Dn
CGCATGGCAGTGAATACTGTTGCAGC
GAAGTATCAGGGGTGAAACTATCCACAAATTG
21
sdrD sdrD-Up
sdrD-Dn
CCACTGGAAATAAAGTTGAAGTTTCAACTGCC
CCTGATTTAACTTTGTCATCAACTGTAATTTGTG
21
sdrE sdrE-Up
sdrE-Dn
GCAGCAGCGCATGACGGTAAAG
GTCGCCACCGCCAGTGTCATTA
21
cna cna-Up
cna-Dn
TTCACAAGCTTGGTATCAAGAGCATGG
GAGTGCCTTCCCAAACCTTTTGAGC
21
clfA clfA-Up
clfA-Dn
ATTGGCGTGGCTTCAGTGCTTG
GCTTGATTGAGTTGTTGCCGGTGT
21
arcA arcA-Up
arcA-Dn
CACGTAACTTGCTAGAACGAG
GAGCCAGAAGTACGCGAG
21
icaA icaA-Up TCAGACACTTGCTGGCGCAGTC
TCA
21
A
s
p
v
f
p
p
i
(icaA-Dn
dditionally, SEs are also associated with other diseases
uch as allergy sensitization, asthma, chronic obstructive
ulmonary disease, scarlet fever, glomerulonephritis, and
asculitis.28–31 The genes encoding these SEs but sej were
ound among S. aureus SSTI isolates, with different carriage
roportions ranging from 6.3% to 35.9% in this investigation. In
articular, the positive rates for seb, sen, and sem among MRSA
solates were signiﬁcantly higher than among MSSA isolates
p < 0.05). The Sdr proteins encoded by the tandemly arrayedCGATTCTCTCCCTCTCTGCCATT
sdrC, sdrD, and sdrE are microbial surface components which
recognize adhesive matrix molecules and have different roles
in S. aureus pathogenicity.32 Strong correlations between S.
aureus invasiveness and the presence of one of the allelic vari-
ants of the sdrE gene, as well as carriage of the sdrD gene
and bone infections caused by S. aureus,  have been reported
previously.33,34 Our previous study showed that 95.5% (85/89)
of S. aureus isolates responsible for bloodstream infection har-
boured at least one sdr locus and 84.3% (75/89) possessed more
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Table 2 – Antimicrobial resistance proﬁles of MRSA,
MSSA, and S. aureus isolates.
MRSA
(n = 57)
R (%)
MSSA (n = 71)
R (%)
S.  aureus
(n = 128)
R  (%)
Tetracycline 36.8 28.2 32.0
Gentamicin 31.6 14.1 21.9
Penicillin 96.5 97.2 96.9
Oxacillin 100 0.0 44.5
Clindamycin 71.9 66.2 68.8
Erythromycin 71.9 67.6 69.5
Ciproﬂoxacin 36.8 15.5 25.0
Linezolid 0 0 0
Rifampicin 10.5 0 4.7
Trimethoprim/
sulfamethoxazole
28.1 19.7 23.4
Nitrofurantoin 0 0 0
Cefaclor 40.4 1.4 18.8
Chloroamphenicol 15.8 5.6 10.2
Imipenem 17.5 0 7.8
Mupirocin 1.8 0 0.8
Dalfopristin/
quinupristin
0 0 0
Vancomycin 0 0 0
Table 3 – The frequencies of virulence genes among S.
aureus, MRSA and MSSA isolates.
S. aureus
(n = 128)
(%)
MRSA
(n  = 57)
(%)
MSSA
(n = 71)
(%)
p-valuesa
sea 35.9 42.1 31.0 >0.05
seb 14.8 21.1 9.9 <0.05
sec 21.1 21.1 21.1
sed 6.3 1.8 9.9 >0.05
seg 26.6 31.6 22.5 >0.05
seh 7.0 3.5 9.9 >0.05
sei 21.1 21.1 21.1
sej 0 0 0
sen 31.3 43.9 21.1 <0.05
sem 30.5 43.9 19.7 <0.05
seo 27.3 26.3 28.2 >0.05
tst 4.7 5.3 4.2 >0.05
eta 7.0 1.8 11.3 >0.05
etb 0 0 0
clfA 99.2 98.2 100 >0.05
cna 32.0 26.3 36.6 >0.05
sdrC 79.7 89.5 71.8 >0.05
sdrD 70.3 70.2 70.4 >0.05
sdrE 72.7 80.7 66.2 <0.05
icaA 96.9 96.5 97.2 >0.05
arcA 0 0 0
pvl 12.5 15.8 9.9 <0.05
hla 95.3 100 91.5 >0.05
hlb 22.7 26.3 19.7 >0.05
hld 100 100 100
hlg 18.8 17.5 19.7 >0.05
edin 5.5 0 9.9 >0.05
a MRSA group was compared with MSSA group. 1 5;1  9(6):614–622
than two sdr loci.35 Similarly, 120 (93.8%) of 128 SSTI isolates in
the present study were found to harbour at least one sdr locus
(sdrC, sdrD, or sdrE), with 18 (14.1%), 39 (30.5%), and 63 (49.2%)
harbouring one, two, or three of these loci, respectively. The
positive rate of sdrE among MRSA isolates was signiﬁcantly
higher than among MSSA isolates. S. aureus isolates produc-
ing TSST-1 encoded by the tst gene have been associated
with toxic shock syndrome, staphylococcal scarlet fever, and
neonatal toxic shock-like exanthematous diseases.3 However,
the present study found that only 4.7% of S. aureus SSTI isolates
harboured tst.  Our previous study found that the prevalence
of hlb among S. aureus isolates associated with bloodstream
infection was 67.4%.35 However, hlb was only identiﬁed among
22.7% of S. aureus SSTI isolates, while the positivity rates of hla
and hld were 95.3% and 100%, respectively.
pvl has been closely associated with CA-MRSA infections
and there is a strong epidemiological association between
carriage of pvl genes and successful CA-MRSA lineages.1,36
Infections caused by pvl-positive S. aureus isolates are pre-
dominantly represented by skin and soft-tissue infection.5,6
Among S. aureus isolates causing SSTI in our hospital between
December 2002 and June 2008, the overall positivity rates of
pvl genes 23.4% (26/111), and among MRSA and MSSA isolates
the rates were, 21.7% (13/60) and 25.5% (13/51), respectively.11
Compared with our previous study, the overall positivity rates
of pvl genes in the present study (12.5%) was lower, as were
the rates among MRSA (15.8%) and MSSA (9.9%) isolates, indi-
cating that there is a decreased trend in the prevalence of pvl
genes among S. aureus SSTI isolates at our hospital.
Molecular  typing
Molecular typing of S. aureus isolates tested are shown in
Table 4. Among 57 MRSA isolates, 24, 14, 13, and three har-
boured SCCmec types III, IV, II, and V, respectively. Three
isolates were classiﬁed as non-typeable.
A total of 28 STs were identiﬁed among 128 S. aureus
isolates. ST7 and ST630 accounting for 10.9% (14/128 each)
were found to be the predominant STs, followed by ST59
(8.6%, 11/128), ST5 (6.3%, 8/128), ST88 (6.3%, 8/128), ST1
(5.5%, 7/128), ST965 (5.5%, 7/128), ST398 (4.7%, 6/128 each),
ST25 (4.7%, 6/128), and ST188 (3.9%, 5/128). ST239, ST6, and
ST121 accounted for four isolates each. ST1463 and ST1821
accounted for three isolates each. ST8 and ST1349 accounted
for two isolates each. The remaining STs including ST12,
ST15, ST118, ST692, ST789, ST1281, ST1920, ST2259, ST2832,
ST2833, and ST72 were identiﬁed in only one isolate. The
STs of nine isolates were not identiﬁed. Two novel STs char-
acterized as ST2832 and 2833 were identiﬁed in two MRSA
isolates and have been deposited in the MLST database
(http://saureus.mlst.net/). Sixteen PVL-positive isolates were
distributed among nine different STs including ST88 (ﬁve iso-
lates), ST59 (three isolates), and ST121 (two isolates). ST239
and ST5 were the most dominant STs in China.9,37 Interest-
ingly, in the present study, these two predominant STs were
found to be minor clones, while ST630 and ST7, seldom noted
in Chinese isolates previously, were the major clones among
S. aureus SSTI isolates. Another study from China found ST398
accounting for 17.1% (28/164) as the most common ST among
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Table 4 – Molecular characteristics of S. aureus SSTIs isolates.
CC (no.) STs (no.) spa types (no.) MRSA (no.) MSSA (no.) SCCmec (no.)
5 (60) ST630 (14) t377 (7) 2 5 III (2)
t4047 (2) 2
t030 (1) 1 III
t4549 (1) 1
t4047 (2) 2 II (1), IV (1)
t5554 (1) 1
ST5 (8) t2460 (2) 2 II (2)
t311 (2) 2  II (2)
t4352 (1) 1 II
t002 (1) 1
t548 (1) 1
t535 (1) 1
ST965 (7) t062 (7) 7 III (4), II (2), NT (1)
ST25 (6) t349 (2) 2
t227 (2) 2 III (2)
t8170 (1) 1
t078 (1) 1
ST188 (5) t189 (4) 1 3 II
t1858 (1) 1 III
ST239 (4) t030 (3) 3 III (3)
t2270 (1) 1 III (1)
ST6 (4) t701 (3) 3
t10519 (1) 1 III
ST1462 (3) t189 (3) 3
ST1821 (3) t377 (1) 1
t2196 (1) 1
t4549 (1) 1 II
ST8 (2) t008 (1) 1
t377 (1) 1
ST15 (1) t062 1
ST118 (1) t189 (1) 1
ST1920 (1) t286 (1) 1
ST72 (1) t148 1
ST1 (7) t127 (7) 2 5 III (2)
7 (15) ST7 (14) t091 (8) 2 6 III (2)
t796 (5) 5
t2828 (1) 1 IV
ST789 (1) t091 (1) 1 III
59 (11) ST59 (11) t437 (8) 7 1 IV (6), V (1)
t163 (3) 2 1 IV (1), NT (1)
88 (8) ST88 (8) t5348 (3) 1 2 IV
t1764 (1) 1 II
t5351 (1) 1
t2788 (1) 1
t7637 1 V
t1376 1 IV
398 (6) ST398 (6) t571 (4) 1 3 IV
t011 (1) 1
t034 (1) 1
S
w
(
o
f
n
p
T121 (4) ST121 (4) t159 (3) 
t2091 (1) 
. aureus SSTI isolates.38 In contrast to our previous study
here ST239 was the most prevalent ST accounting for 21.6%
24/111) of S. aureus SSTI isolates,11 this ST accounted for
nly 3.1% (4/128) in the present study. Interestingly, ST630 not
ound in our previous study turned out to be the predomi-
ant ST in the present study, while ST1018, the second most
revalent ST in our previous study, was not found.
Fifty-two spa types were identiﬁed among the 128 isolates.
he most prevalent spa type was t091 (8.6%, 11/128), followed2 1 III (1), IV (1)
1
by t062 (7.0%, 9/128), t377 (7.0%, 9/128), t437 (7.0%, 9/128), t189
(6.3%, 8/128), t127 (4.7%, 6/128), t796 (3.9%, 4/128), t571 (3.1%,
3/128), t4047 (3.1%, 3/128), and t030 (3.1%, 3/128). Other types
identiﬁed included t159, t163, t5348, and t701 (three isolates
each). In previous reports of Chinese isolates, t30 and t37,
typically associated with ST239, were the most prevalent spa
types.9,15 The proportions of t37 and t30 were extremely low,
as well as the proportions of ST239 and ST5 in the present
study.
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Table 5 – Speciﬁc antimicrobial resistance and virulence
gene proﬁles of major CCs.
CC5 (n = 67)
(%)
CC7 (n = 15)
(%)
CC59 (n = 11)
(%)
Virulence genes
sea 37.3 23.3 27.3
seb 7.5 13.3 54.5
sec 19.4 0 63.6
sed 10.4 6.7 0
seg 34.3 0 27.3
seh 11.8 0 0
sei 29.8 6.7 0
sen 44.8 6.7 27.3
sem 40.3 6.7 9.1
seo 34.3 0 0
tst 7.5 0 0
eta 9 6.7 9.1
clfA 100 100 100
cna 38.8 0 0
sdrC 89.6 93.3 54.5
sdrD 82.1 100 9.1
sdrE 82.1 26.7 100
icaA 95.5 100 100
pvl 4.5 0 27.3
hla 91.0 93.3 100
hlb 26.9 0 45.5
hld 100 100 100
hlg 10.4 13.3 27.3
edin 4.5 0  0
Antimicrobial agents
MRSA 43.3 26.7 81.8
Tetracycline 25.4 66.7 45.5
Gentamycin 25.4 40.0 0
Penicillin 97 93.3 100
Clindamycin 59.7 73.3 81.8
Erythromycin 62.7 73.3 81.8
Ciproﬂoxacin 35.8 6.7 18.2
Rifampicin 7.5 0 0
Trimethoprim/
sulfamethoxazole
20.9 40 0
Chloroamphenicol 9.0 0 27.3620  b r a z j i n f e c t d 
Fifty-seven MRSA isolates were distributed in different
clones. 12.3% (7/57) of MRSA isolates belonged to MRSA-
ST59-SCCmec  IV-t  437/163, which was the most common
clone in the present study. Likewise, in a study from China
ST59-MRSA-IVa-t437 was found to be the predominant clone
among CA-MRSA isolates associated with SSTIs in children.39
Our previous study conducted between December 2002 and
June 2008 found that ST239-MRSA-SCCmec III accounting for
30.2% (19/63) was the most prevalent clone among MRSA
SSTI isolates, followed by ST1018-MRSA-SCCmecIII account-
ing for 15.9% (10/63).11 However, only three MRSA isolates
were ST239-MRSA-SCCmec III and there was no ST1018-
MRSA-SCCmecIII isolate in the present study. Among 71
MSSA isolates, the dominant clone was MSSA-ST7 (15.5%,
11/71), followed by MSSA-ST630 (12.7%, 9/71), MSSA-ST398 and
MSSA-ST1 (7.0%, 5/71 each), and MSSA-ST25 and MSSA-ST88
(5.6%, 4/71 each). MRSA-ST398 isolates are usually associated
with infections in both animals and humans.40,41 ST398 MSSA
isolates of human origin are usually linked to t571.42 In the
present study, four of six ST-398 S. aureus isolates, including
three MSSA and one MRSA isolate, were linked to t571.
Taken together, our data showed that S. aureus isolates
associated with SSTIs were genetically diverse and the main
clones associated with SSTIs are going through a rapid shift in
our hospital.
Comparison  of  antimicrobial  resistance  and  molecular
typing among  the  major  clonal  complexes  (CCs)
Clustering analysis by eBURST v3 showed that six clonal
complexes (CCs) were found (Table 4), including CC5 (52.3%,
67/128), CC7 (11.7%, 15/128), CC59 (8.6%, 11/128), CC88 (6.3%,
8/128), and CC398 (4.7%, 6/128). The distribution of some vir-
ulence genes, especially enterotoxin genes, were correlated
with different MRSA lineages.43,44 In the present study, a
higher carriage of seb and sec was found among CC59 iso-
lates, while a higher carriage of enterotoxin genes were found
among CC5 isolates (Table 5). All CC7 and CC59 isolates were
not carrying seh and seo, while 11.8% and 34.2% of CC5 isolates
were found to carry these two genes, respectively. Although
the proportions of seb and sec among CC5 and CC7 isolates
were low, the positivity rates of these two enterotoxin genes
among CC59 isolates were 54.5% (seb) and 63.6% (sec). The
prevalence of cna among CC5 isolates was 38.8%, while this
virulence gene was identiﬁed in none of the CC7 and CC59
isolates. Compared with the higher carriage rates (>80.0%) of
sdrC and sdrD among CC5 and CC7 isolates, the positivity rates
of two sdr loci were signiﬁcantly lower among CC59 isolates,
especially sdrD prevalence of 9.1%. Interestingly, all CC59 iso-
lates carried sdrE, while only 26.7% of CC7 isolates were found
to carry sdrE. The carriage rates of pvl and hlb among CC59
isolates were signiﬁcantly higher than those rates among CC5
and CC7 isolates (p < 0.05). These differences in carriage rates
of virulence genes among different CC isolates suggested that
different S. aureus lineages associated with SSTIs have speciﬁc
patterns of virulence genes.The predominant MRSA clones in China were associ-
ated with speciﬁc antimicrobial resistance proﬁles.45 In the
present study, although 81.8% of CC59 isolates were MRSA, all
isolates were susceptible to gentamicin, rifampicin, andMupirocin 0 6.7 0
trimethoprim/sulfamethoxazole (Table 5). However,
the resistance rates for gentamicin and trimetho-
prim/sulfamethoxazole were respectively 25.4% and 20.9%
among CC5 isolates, and 40.0% and 40.0% among CC7 isolates
(Table 5). The resistance rates for tetracycline, clindamycin,
and erythromycin among CC5 isolates were relatively lower
relative to CC7 and CC59 isolates (Table 5). As the prevalence
of MRSA among CC7 isolates was lower than CC5 and CC59
isolates, the resistance rates of some antimicrobial agents
among CC7 isolates were lower than other CC isolates, such as
ciproﬂoxacin and chloramphenicol. However, only one isolate
with resistance to mupirocin in this investigation belonged
to CC7.
In conclusion, the molecular characteristic of S. aureus
SSTI isolates in the present study showed considerable het-
erogeneity and ST7 and ST630 were the prevalent clones.
Different S. aureus clones causing SSTIs were associated
with speciﬁc antimicrobial resistance and virulence gene
proﬁles.
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